Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1 × Has announcements × Tislelizumab × Clear all

Sponsor

Conditions

Recurrence 3 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hematologic Neoplasms 2 Solid Tumors Harboring NTRK Fusion 1 Skin Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mastocytosis, Systemic 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Solid Tumors 1 Leukemia, Myeloid, Acute 1 Leukemia, Mast-Cell 1 Head and Neck Neoplasms 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡